BCL2 and breast carcinoma: Similarly, Bu et al. also found CDCA8 as a tumor promotor in estrogen-stimulated cell proliferation of breast cancer, which induced downregulation of CCND1 and Bcl-2, and upregulation of P21 and P27, and could predict poor prognosis 20.